Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Paclitaxel tumor priming promotes delivery and transfection of intravenous lipid-siRNA in pancreatic tumors.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Paclitaxel tumor priming promotes delivery and transfection of intravenous lipid-siRNA in pancreatic tumors.
Paclitaxel tumor priming promotes delivery and transfection of intravenous lipid-siRNA in pancreatic tumors. J Control Release. 2015 Oct 28; 216:103-10.
View in:
PubMed
subject areas
Animals
Animals
Antineoplastic Agents, Phytogenic
Antineoplastic Agents, Phytogenic
Cell Line, Tumor
Cell Line, Tumor
Drug Delivery Systems
Drug Delivery Systems
Drug Resistance, Neoplasm
Drug Resistance, Neoplasm
Female
Female
Gene Silencing
Gene Silencing
Genetic Therapy
Genetic Therapy
Humans
Humans
Inhibitor of Apoptosis Proteins
Inhibitor of Apoptosis Proteins
Injections, Intravenous
Injections, Intravenous
Lipids
Lipids
Mice
Mice
Mice, Nude
Mice, Nude
Paclitaxel
Paclitaxel
Pancreatic Neoplasms
Pancreatic Neoplasms
Peritoneal Neoplasms
Peritoneal Neoplasms
RNA, Neoplasm
RNA, Neoplasm
RNA, Small Interfering
RNA, Small Interfering
Transfection
Transfection
Xenograft Model Antitumor Assays
Xenograft Model Antitumor Assays